Maximising data capture in obesity trials
ICON's imaging strategy against 'silent attrition'
In Association With ICON
Meet critical milestones
Enhancing clinical trials in obesity by integrating clinical outcome assessments (COAs) and digital health technologies (DHTs)
The impact of drug pricing and reimbursement on the pharmaceutical industry
Obesity therapies and the multi-indication momentum: how industry is responding
A dynamic market: Trends transforming the future of obesity drug development
How CNS researchers are handling clinical trial turbulence
Designing clinical trials for a complex disease: pediatric obesity
Oncology R&D: emerging therapies and new challenges
